Fresenius Medical Care AG... (FMS)
23.48
-0.73 (-3.02%)
At close: Mar 03, 2025, 3:59 PM
23.22
-1.11%
Pre-market: Mar 04, 2025, 06:05 AM EST
Fresenius Medical Care AG & Co. KGaA Income Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 |
Revenue | 19.34B | 19.45B | 19.4B | 17.62B | 17.86B | 17.48B | 16.55B | 17.78B | 17.03B | 15.31B | 13.02B | 10.58B | 10.43B | 9.87B | 9.06B | 7.85B | 7.62B | 6.67B | 6.44B | 5.72B | 4.59B | 4.39B | 4.84B | 5.46B | 4.47B | 3.82B | 2.99B | 2.96B |
Cost of Revenue | 14.58B | 14.53B | 14.09B | 12.54B | 12.32B | 12.08B | 11.39B | 11.78B | 11.53B | 10.43B | 8.91B | 7.15B | 6.96B | 6.38B | 5.95B | 5.18B | 5.02B | 4.37B | 4.26B | 3.75B | 3.06B | 2.94B | 3.27B | 3.62B | 2.91B | 2.13B | 1.64B | n/a |
Gross Profit | 4.76B | 4.93B | 5.31B | 5.08B | 5.54B | 5.4B | 5.16B | 6B | 5.5B | 4.88B | 4.11B | 3.43B | 3.48B | 3.49B | 3.12B | 2.67B | 2.61B | 2.3B | 2.18B | 1.97B | 1.54B | 1.45B | 1.58B | 1.84B | 1.56B | 1.69B | 1.35B | 2.96B |
Operating Income | 1.39B | 1.37B | -258.36M | 301.32M | 529M | 710M | 3.04B | 2.36B | 2.51B | 2.13B | 1.85B | 1.63B | 1.68B | 1.6B | 1.45B | 1.23B | 1.2B | 1.08B | 998.73M | 792.74M | 628.76M | 601.43M | 662.28M | 426.21M | 661M | 556.74M | 416.87M | 2.96B |
Interest Income | 71.58M | 88.22M | 68M | 73M | 42M | 62M | 147M | 43M | 44.69M | 107.02M | 69.08M | 28.2M | 33.63M | 46.16M | 19.11M | 14.93M | 17.82M | 19.61M | 15.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 1.06B | 1.03B | 1.22B | 1.57B | 1.94B | 1.84B | 2.74B | 2.01B | 2.12B | 1.77B | 1.52B | 1.34B | 1.46B | 1.37B | 1.24B | 1.02B | 959.48M | 829.27M | 732.6M | 646.51M | 493.21M | 431.87M | 461.6M | 173.71M | 427.86M | -259.67M | 131.74M | n/a |
Net Income | 537.91M | 499M | 673.4M | 969.31M | 1.16B | 1.2B | 1.98B | 1.28B | 1.18B | 941.19M | 859.37M | 803.76M | 897.39M | 826.45M | 735.75M | 621.98M | 587.32M | 491.86M | 406.69M | 384.12M | 296.55M | 262.97M | 276.16M | 71.2M | 225.8M | -247M | 16.29M | 82M |
Selling & General & Admin | 3.14B | 3.2B | 3.78B | 3.1B | 3.17B | 3.06B | 2.87B | 3.58B | 2.9B | 2.65B | 2.18B | 1.73B | 1.68B | 1.83B | 1.6B | 1.38B | 1.35B | 1.17B | 1.17B | 1.13B | 872.07M | 811.32M | 870.65M | 1.09B | 866.7M | 818.01M | 665.07M | n/a |
Research & Development | 183.49M | 231.97M | 229M | 221M | 194M | 168M | 134M | 131M | 154.04M | 128.05M | 100.33M | 91.11M | 84.41M | 85.51M | 72.58M | 65.48M | 57.64M | 45.63M | 38.86M | 43.02M | 37.89M | 39.45M | 45.2M | 40.12M | 34M | 32.29M | 26.6M | n/a |
Other Expenses | 37.95M | 127.26M | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | 75.61M | n/a | 0.00 | n/a | n/a | n/a | -30.48M | n/a | 0.00 | n/a | n/a | 290.15M | n/a | 282.44M | 237.89M | n/a |
Operating Expenses | 3.36B | 3.56B | 4.01B | 3.32B | 3.36B | 3.23B | 3B | 3.71B | 3.05B | 2.78B | 2.28B | 1.82B | 1.84B | 1.89B | 1.67B | 1.45B | 1.41B | 1.22B | 1.18B | 1.18B | 909.96M | 850.78M | 915.85M | 1.42B | 900.7M | 1.13B | 929.57M | n/a |
Interest Expense | 407.04M | 424.64M | 360M | 353M | 410M | 491M | 448M | 397M | 430.73M | 464.65M | 407.07M | 324.07M | 355.79M | 274.95M | 229.69M | 224.3M | 259.72M | 274.1M | 281.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 776.53M | 807.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.94B | 18.08B | 18.1B | 15.86B | 15.68B | 15.31B | 14.39B | 15.49B | 14.58B | 13.21B | 11.19B | 8.97B | 8.8B | 8.27B | 7.62B | 6.62B | 6.42B | 5.58B | 5.44B | 4.92B | 3.97B | 3.79B | 4.18B | 5.04B | 3.81B | 3.26B | 2.57B | n/a |
Income Tax | 316.06M | 300.56M | 325M | 353M | 501M | 402M | 511M | 454M | 649.42M | 569.83M | 480.26M | 428.72M | 457.57M | 463.78M | 434.86M | 342.29M | 351.37M | 319.38M | 313.3M | 260.68M | 195.79M | 168.9M | 174.22M | 102.5M | 202.06M | -12.66M | 115.45M | -82M |
Shares Outstanding (Basic) | 293.41M | 293.41M | 293.25M | 292.94M | 294.06M | 302.69M | 613.08M | 613.13M | 611.5M | 608.88M | 604.68M | 607.63M | 610.22M | 605.95M | 596.24M | 596.52M | 594.06M | 591.34M | 588.39M | 583.27M | 466.67M | 420M | 420M | 420M | 536.9M | 473.42M | 420M | 420M |
Shares Outstanding (Diluted) | 293.41M | 293.41M | 293.25M | 293.07M | 294.28M | 302.75M | 614.55M | 615.28M | 613.39M | 610.19M | 605.95M | 607.63M | 613.34M | 610.34M | 604.02M | 596.66M | 595.81M | 593.75M | 592.02M | 588.3M | 644.11M | 420M | 420M | 420M | 539.17M | 473.42M | 420M | 420M |
EPS (Basic) | 1.83 | 1.70 | 2.30 | 3.31 | 3.96 | 3.96 | 3.23 | 2.09 | 1.87 | 1.57 | 1.42 | 1.32 | 1.47 | 1.37 | 1.22 | 1.04 | 0.99 | 0.83 | 0.69 | 0.66 | 0.51 | 0.45 | 0.48 | 0.12 | 0.42 | -0.52 | 0.03 | 0.18 |
EPS (Diluted) | 1.83 | 1.70 | 2.30 | 3.31 | 3.96 | 3.96 | 3.23 | 2.08 | 1.87 | 1.57 | 1.42 | 1.32 | 1.46 | 1.35 | 1.22 | 1.04 | 0.98 | 0.83 | 0.69 | 0.65 | 0.51 | 0.45 | 0.48 | 0.12 | 0.42 | -0.52 | 0.03 | 0.18 |
EBITDA | 3.21B | 3.21B | 1.58B | 3.55B | 4.13B | 3.92B | 2.91B | 3B | 3.04B | 2.8B | 2.5B | 2.13B | 2.14B | 2.08B | 1.84B | 1.56B | 1.52B | 1.33B | 1.2B | 1.01B | 800.33M | 773.24M | 862.94M | 789.79M | 1B | 839.18M | 654.81M | 2.96B |
Depreciation & Amortization | 1.74B | 1.75B | 1.72B | 1.59B | 1.59B | 1.55B | 724.85M | 735.48M | 701.54M | 655.81M | 574.83M | 469.43M | 455.87M | 429.75M | 378.37M | 318.97M | 298.59M | 249.2M | 233.9M | 212.3M | 171.57M | 171.81M | 200.65M | 363.59M | 311.81M | 282.44M | 237.89M | n/a |